YIH
TNGX icon

Y-Intercept (HK)’s Tango Therapeutics TNGX Stock Holding History

Y-Intercept (HK)’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,330
Closed -$526K – 2058
2025
Q4 		$526K Buy
59,330
+22,367
+61% +$193K 0.01% 1222
2025
Q3 		$310K Buy
+36,963
New +$250K 0.01% 1370
2022
Q2 		– Sell
-20,305
Closed -$154K – 1191
2022
Q1 		$154K Buy
+20,305
New +$176K 0.04% 646

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Y-Intercept (HK)'s TNGX Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 59,330 shares — an estimated $526K sold.

Y-Intercept (HK) first reported a position in TNGX in Q1 2022 and held it in 3 quarters. The position peaked at $526K in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 59,330 Tango Therapeutics shares in Q1 2026, an estimated $526K.
  • Y-Intercept (HK) first reported a position in Tango Therapeutics in Q1 2022 and held it in 3 quarters.
  • Y-Intercept (HK)'s Tango Therapeutics position peaked at $526K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.